Switch theme
Sign up to access all valuation multiples
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
1988
116
Last FY Revenue $9.4M
Last FY EBITDA $0.8M
$19.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, EBM Technologies achieved revenue of $9.4M and an EBITDA of $0.8M.
EBM Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See EBM Technologies valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $9.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $5.9M | XXX | XXX | XXX |
| Gross Margin | XXX | 63% | XXX | XXX | XXX |
| EBITDA | XXX | $0.8M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 8% | XXX | XXX | XXX |
| EBIT | XXX | $0.1M | XXX | XXX | XXX |
| EBIT Margin | XXX | 1% | XXX | XXX | XXX |
| Net Profit | XXX | $0.1M | XXX | XXX | XXX |
| Net Margin | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, EBM Technologies's stock price is TWD 22 (or $1).
EBM Technologies has current market cap of TWD 688M (or $22.9M), and EV of TWD 596M (or $19.9M).
See EBM Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19.9M | $22.9M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, EBM Technologies has market cap of $22.9M and EV of $19.9M.
EBM Technologies's trades at 2.1x EV/Revenue multiple, and 25.9x EV/EBITDA.
Equity research analysts estimate EBM Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
EBM Technologies's P/E ratio is not available.
See valuation multiples for EBM Technologies and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $22.9M | XXX | $22.9M | XXX | XXX | XXX |
| EV (current) | $19.9M | XXX | $19.9M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 25.9x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 178.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 321.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 5.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEBM Technologies's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
EBM Technologies's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
EBM Technologies's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for EBM Technologies and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 21% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 62% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
EBM Technologies acquired XXX companies to date.
Last acquisition by EBM Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . EBM Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was EBM Technologies founded? | EBM Technologies was founded in 1988. |
| Where is EBM Technologies headquartered? | EBM Technologies is headquartered in Taiwan. |
| How many employees does EBM Technologies have? | As of today, EBM Technologies has 116 employees. |
| Is EBM Technologies publicy listed? | Yes, EBM Technologies is a public company listed on ROCO. |
| What is the stock symbol of EBM Technologies? | EBM Technologies trades under 8409 ticker. |
| When did EBM Technologies go public? | EBM Technologies went public in 2012. |
| Who are competitors of EBM Technologies? | Similar companies to EBM Technologies include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of EBM Technologies? | EBM Technologies's current market cap is $22.9M |
| Is EBM Technologies profitable? | Yes, EBM Technologies is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
